PEBP1 and diabetic kidney disease: showed that icariin, a bioactive flavonoid compound, attenuates renal fibrosis and endothelial mesenchymal transition in diabetic nephropathy by upregulating RKIP expression and inhibiting the AR/RKIP/MEK/ERK signaling pathway (186).